Neuehealth EVP Tomas Orozco sells shares price $9,037

In a current submitting with the Securities and Alternate Fee, it was disclosed that Tomas Orozco, Government Vice President of Shopper Care at NeueHealth, Inc. (NASDAQ:NEUE), bought a portion of his holdings within the firm. The transaction, dated January 6, 2025, concerned the sale of 1,233 shares of widespread inventory at a weighted common worth of $7.33 per share, leading to a complete transaction worth of roughly $9,037. Based on InvestingPro information, the inventory has proven robust momentum with a 44% achieve over the previous six months, although it stays considerably beneath its 52-week excessive of $16.59.

The shares had been bought to cowl tax withholding obligations following the vesting of restricted inventory items. This transaction was not discretionary, as famous within the submitting. Following this sale, Orozco retains possession of seven,830 shares within the firm. InvestingPro evaluation signifies the corporate at present trades beneath its Honest Worth, with 12 extra funding insights out there to subscribers.

NeueHealth, Inc., beforehand referred to as Vibrant Well being Group Inc (NYSE:NEUE)., operates within the hospital and medical service plans trade. The corporate is headquartered in Doral, Florida. The corporate reported income of $997 million within the final twelve months, although analysts anticipate gross sales decline within the present yr.

In different current information, RBC Capital has revised its worth goal for NeueHealth from $8.00 to $7.00, sustaining a Sector Carry out ranking on the corporate’s inventory. This adjustment comes within the wake of the corporate’s third-quarter outcomes, which surpassed expectations regardless of a year-over-year income decline of 9.01%. The corporate’s present ratio, a key liquidity indicator, stands at a regarding 0.68, though the administration has confirmed that their steerage stays unchanged.

RBC Capital’s new worth goal displays an up to date valuation mannequin for NeueHealth, bearing in mind its third-quarter efficiency and aligning the valuation with the upcoming fiscal interval. The agency’s Sector Carry out ranking suggests a impartial stance on NeueHealth’s inventory, predicting it would carry out in keeping with sector expectations.

Traders can think about this revised worth goal and ranking of their analysis of NeueHealth’s inventory for portfolio inclusion. Based on InvestingPro evaluation, the inventory seems undervalued at present ranges. These are among the many newest developments for the corporate.

This text was generated with the assist of AI and reviewed by an editor. For extra data see our T&C.